General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics Capital to fuel Company’s strategic growth into a leading biologics platform in the Southeast Asia region Jakarta, Indonesia – January 27, 2021 – Kalbe Genexine Biologics (“KGBio” or “the Company”), a leading integrate biologics holding company focused on the...
Kalbe Group Continues to Consider Growth Initiatives Kalbe Group Continues to Consider Growth Initiatives The impact of COVID-19 pandemic has brought about unprecedented challenges to the lives of Indonesian people. As a company in the health sector, PT Kalbe Farma Tbk (“Kalbe”) is...
Optimism in the Midst of a Pandemic Optimism in the Midst of a Pandemic The COVID-19 Pandemic causing a worldwide health and economic crisis. Entering the year 2021, I am sure our country, Indonesia, is capable of getting up and make numerous innovation...